+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Long-term, tunneled, noncuffed central venous catheter in cancer patients (Vygon): safety, efficacy, and complications



Long-term, tunneled, noncuffed central venous catheter in cancer patients (Vygon): safety, efficacy, and complications



Supportive Care in Cancer 14(11): 1141-1146



Totally implantable or partially cuffed central venous catheters (CVC) are commonly used in cancer patients, but they are often expensive and may produce complications. To minimize costs, we have been using a low-cost, partially tunneled, silicone elastomer catheter with no Dacron cuff or antireflux valve (Vygon) since 2001. This study is a retrospective investigation of our experience using the Vygon catheter as a long-term CVC in patients with malignancy. A total of 458 Vygon catheters (Nutricath, Vygon) were percutaneously inserted by an interventional radiologist in 302 cancer patients. The median duration of catheter use was 93 days, mean 164.3 days (range 1-789). Main patient characteristics were as follows: number of male/female patients, 166/136; median age, 51 years; hematological/nonhematological patients, 189/113. Early complications were pneumothorax in six and hematoma in twelve of 458 implants, respectively. Thirteen out of 302 patients developed a catheter-related thrombosis. One hundred and thirty-five of 458 Vygon catheters required removal because of catheter-related complications: 68 accidental losses, 37 cases of febrile neutropenia suspected to be catheter-related, ten catheter dislodgements, ten catheter malfunctions, four local infections, three thromboses, two catheter ruptures, and one allergic reaction. Vygon catheters do not seem to induce more early and late complications as compared with other more expensive devices, except for disadvantage of the high incidence rate of accidental losses.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 049493419

Download citation: RISBibTeXText

PMID: 16622649

DOI: 10.1007/s00520-006-0065-2


Related references

Central Venous Catheter Salvage in Home Parenteral Nutrition Catheter-Related Bloodstream Infections: Long-Term Safety and Efficacy Data. Jpen. Journal of Parenteral and Enteral Nutrition 40(5): 699-704, 2017

Long term parenteral therapy by percutaneous tunneled silicone central venous catheter--a follow-up of 300 catheters. Clinical Nutrition 1(2): 117-124, 1982

The pathogenesis of catheter-related bloodstream infection with noncuffed short-term central venous catheters. Intensive Care Medicine 30(1): 62-67, 2003

Efficacy and safety of reteplase for central venous catheter occlusion in patients with cancer. Journal of Vascular and Interventional Radiology 15(1 Pt 1): 39-44, 2004

Correlation between "malfunctioning events" and catheter-related infections in pediatric cancer patients bearing tunneled indwelling central venous catheter: results of a prospective observational study. Supportive Care in Cancer 13(9): 757-759, 2005

Inflammation at the insertion site is not predictive of catheter-related bloodstream infection with short-term, noncuffed central venous catheters. Critical Care Medicine 30(12): 2632-2635, 2002

Trimming long-term tunneled central venous catheters in pediatric patients. Pediatric Blood and Cancer 60(1): 152-155, 2013

Long-term management of the tunneled venous catheter. Seminars in Dialysis 19(2): 158-164, 2006

Tunneled central venous catheter complications and the iatrogenic superior vena cava syndrome. New York State Journal of Medicine 92(2): 43-44, 1992

Thrombin-activated inhibitor of fibrinolysis and efficacy and safety of long-term warfarin treatment in patients with venous thromboembolic complications. Terapevticheskii Arkhiv 83(12): 43-48, 2012

Interventions to obstructive long-term central venous catheter in cancer patients: a meta-analysis. Supportive Care in Cancer 2018, 2018

Long-term central venous catheter infection in HIV-infected and cancer patients: a multicenter cohort study. Infection Control and Hospital Epidemiology 20(7): 494-498, 1999

A prospective evaluation of central venous blood flow using Doppler ultrasound in patients with a long-term central venous catheter. European Journal of Clinical Nutrition 51(2): 123-124, 1997

Fourteen years of hemodialysis with a central venous catheter: mechanical long-term complications. Journal of Vascular Access 7(2): 60-65, 2006

Efficacy and Safety of a New Technique of Conversion from Temporary to Tunneled Central Venous Catheters. Seminars in Dialysis 28(4): 435-438, 2016